Explore Doctor Care Anywhere Group's Fair Values from the Community and select yours

Insiders who bought Doctor Care Anywhere Group PLC (ASX:DOC) stock in the last 12 months were richly rewarded last week. The company's market value increased by AU$5.5m as a result of the stock's 12% gain over the same period. As a result, the stock they originally bought for UK£352.3k is now worth UK£682.3k.

Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

The Last 12 Months Of Insider Transactions At Doctor Care Anywhere Group

In the last twelve months, the biggest single purchase by an insider was when insider Alexander Waislitz bought AU$178k worth of shares at a price of AU$0.071 per share. Even though the purchase was made at a significantly lower price than the recent price (AU$0.14), we still think insider buying is a positive. While it does suggest insiders consider the stock undervalued at lower prices, this transaction doesn't tell us much about what they think of current prices.

While Doctor Care Anywhere Group insiders bought shares during the last year, they didn't sell. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

Check out our latest analysis for Doctor Care Anywhere Group

Doctor Care Anywhere Group is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Insiders At Doctor Care Anywhere Group Have Bought Stock Recently

Over the last three months, we've seen a bit of insider buying at Doctor Care Anywhere Group. Independent Chairman of the Board John Stier shelled out AU$42k for shares in that time. We like it when there are only buyers, and no sellers. But the amount invested in the last three months isn't enough for us too put much weight on it, as a single factor.

Does Doctor Care Anywhere Group Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 37% of Doctor Care Anywhere Group shares, worth about AU$20m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Does This Data Suggest About Doctor Care Anywhere Group Insiders?

Our data shows a little insider buying, but no selling, in the last three months. Overall the buying isn't worth writing home about. On a brighter note, the transactions over the last year are encouraging. Insiders do have a stake in Doctor Care Anywhere Group and their transactions don't cause us concern. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 2 warning signs for Doctor Care Anywhere Group (of which 1 is potentially serious!) you should know about.

But note: Doctor Care Anywhere Group may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.